Evidence map›Paper›PMID 11752161›Full record

ArticleJournal of virology2002

Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.

Tuofu Zhu, David Muthui, Sarah Holte, David Nickle, Feng Feng, Scott Brodie, Yon Hwangbo, James I Mullins, Lawrence Corey

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 166 papers.

0numbers the graph read from it
0cells of the map it votes in
166citing papers in PubMed
5.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

166 citing papers in PubMed, 295 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. CD3bioRxiv : the preprint server for biology · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

106 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tuofu ZhuDepartment of Laboratory Medicine, University of Washington School of Medicine, Seattle, Washington 98195, USA. tzhu@u.washington.edu
David Muthui
Sarah Holte
David Nickle
Feng Feng
Scott Brodie
Yon Hwangbo
James I Mullins
Lawrence Corey
University of Washington · USCancer Research And Biostatistics · USFred Hutch Cancer Center · US

Funding

IMMUNOLOGY AND MOLECULAR VIROLOGY OF ACUTE HIV INFECTIONU01AI041535 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI COREY, LAWRENCE · 1997 to 2003
$6.0M
Mucosal CTL Induction After HIV Exposure &VaccinationR37AI035605 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI MCELRATH, MARGARET JULIANA · 1998 to 2007
$3.4M
Role of CD14+ Monocytes in HIV-1 InfectionR01AI049109 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 2001 to 2005
$1.3M
SUPPRESSING HIV INFECTION IN EXPOSED SERONEGATIVE ADULTSR01AI045402 · NIAID · UNIVERSITY OF WASHINGTON · PI ZHU, TUOFU · 1999 to 2003
$873k
AIDS VACCINE EVALUATION UNITSN01AI045206 · NIAID · UNIVERSITY OF WASHINGTON · PI COREY, LAWRENCE · 1994 to 2000
$39k
CMIG FOR AIDS VACCINER01AI035605 · NIAID · UNIVERSITY OF WASHINGTON · PI MCELRATH, MARGARET JULIANA · 1994 to 1997
–
NIAID NIH HHS AI35605NIAID NIH HHS AI41535NIAID NIH HHS AI45206NIAID NIH HHS AI45402NIAID NIH HHS AI49109NIAID NIH HHS R01 AI045402NIAID NIH HHS R01 AI049109NIAID NIH HHS R37 AI035605
6 · The paper itself

Abstract

In vitro studies show that human immunodeficiency virus type 1 (HIV-1) does not replicate in freshly isolated monocytes unless monocytes differentiate to monocyte-derived macrophages. Similarly, HIV-1 may replicate in macrophages in vivo, whereas it is unclear whether blood monocytes are permissive to productive infection with HIV-1. We investigated HIV-1 replication in CD14(+) monocytes and resting and activated CD4(+) T cells by measuring the levels of cell-associated viral DNA and mRNA and the genetic evolution of HIV-1 in seven acutely infected patients whose plasma viremia had been <100 copies/ml for 803 to 1,544 days during highly active antiretroviral therapy (HAART). HIV-1 DNA was detected in CD14(+) monocytes as well as in activated and resting CD4(+) T cells throughout the course of study. While significant variation in the decay slopes of HIV-1 DNA was seen among individual patients, viral decay in CD14(+) monocytes was on average slower than that in activated and resting CD4(+) T cells. Measurements of HIV-1 sequence evolution and the concentrations of unspliced and multiply spliced mRNA provided evidence of ongoing HIV-1 replication, more pronounced in CD14(+) monocytes than in resting CD4(+) T cells. Phylogenetic analyses of HIV-1 sequences indicated that after prolonged HAART, viral populations related or identical to those found only in CD14(+) monocytes were seen in plasma from three of the seven patients. In the other four patients, HIV-1 sequences in plasma and the three cell populations were identical. CD14(+) monocytes appear to be one of the potential in vivo sources of HIV-1 in patients receiving HAART.

Indexed as

Antiretroviral Therapy, Highly ActiveVirus ReplicationAmino Acid SequenceAnti-HIV AgentsCD4-Positive T-LymphocytesCell DivisionEvolution, MolecularGene Expression Regulation, ViralHalf-LifeHIV-1HIV Envelope Protein gp120HIV InfectionsHumansLipopolysaccharide ReceptorsLymphocyte ActivationMaleAnti-HIV AgentsHIV Envelope Protein gp120Lipopolysaccharide ReceptorsRNA, Viral

Identifiers

PMID11752161
PMCPMC136806
OpenAlexW2042982138

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.